Skip to main content

[vc_row][vc_column][vc_single_image image="69612" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]A collaborative study published in Science Advances reveals how the physical and metabolic conditions within the tumor microenvironment, particularly when combined with elevated blood sugar (hyperglycemia), enable cancer cells to form a thick, sugar-coated shield that hides them from immune...

[vc_row][vc_column][vc_empty_space][vc_raw_html css=""]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[/vc_raw_html][vc_empty_space height="22px"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] In a new episode of All Things Cancer, NFCR President and CEO Dr. Sujuan Ba interviews Dr. Monica Bertagnolli—former Director of both the National Cancer Institute and the National Institutes of Health. Their conversation touches on the state of U.S. cancer research,...

[vc_row][vc_column][vc_empty_space][vc_raw_html css=""]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[/vc_raw_html][vc_empty_space height="22px"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]  “What’s next for cancer research?” It’s a question that drives every scientist, clinician, and innovator in the NFCR network—and one that takes center stage in the newest episode of All Things Cancer, hosted by NFCR President and CEO Dr. Sujuan Ba. In this special...

[vc_row disable_element="yes"][vc_column][vc_column_text css=""] All Things Cancer Episode #10: Harnessing the Immune System with Drew Pardoll [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][vc_raw_html css=""]JTNDaWZyYW1lJTIwZGF0YS10ZXN0aWQlM0QlMjJlbWJlZC1pZnJhbWUlMjIlMjBzdHlsZSUzRCUyMmJvcmRlci1yYWRpdXMlM0ExMnB4JTIyJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZvcGVuLnNwb3RpZnkuY29tJTJGZW1iZWQlMkZlcGlzb2RlJTJGMmtFY2RRaFpjTmRTeDJmZXNsZGFzVSUzRnV0bV9zb3VyY2UlM0RnZW5lcmF0b3IlMjIlMjB3aWR0aCUzRCUyMjEwMCUyNSUyMiUyMGhlaWdodCUzRCUyMjM1MiUyMiUyMGZyYW1lQm9yZGVyJTNEJTIyMCUyMiUyMGFsbG93ZnVsbHNjcmVlbiUzRCUyMiUyMiUyMGFsbG93JTNEJTIyYXV0b3BsYXklM0IlMjBjbGlwYm9hcmQtd3JpdGUlM0IlMjBlbmNyeXB0ZWQtbWVkaWElM0IlMjBmdWxsc2NyZWVuJTNCJTIwcGljdHVyZS1pbi1waWN0dXJlJTIyJTIwbG9hZGluZyUzRCUyMmxhenklMjIlM0UlM0MlMkZpZnJhbWUlM0U=[/vc_raw_html][vc_empty_space height="22px"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]The National Foundation for Cancer Research’s All Things Cancer podcast recently featured a wide-ranging conversation between NFCR President and CEO Sujuan Ba and pioneering cancer immunologist Drew Pardoll. Their discussion...

[vc_row][vc_column][vc_single_image image="63621" img_size="full" alignment="center" css=""][vc_column_text css=""] From Curiosity to Cure [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]The latest episode of All Things Cancer features a powerful conversation with Nobel Laureate Dr. James Allison, whose work in immunotherapy has transformed cancer treatment across the globe. Hosted by Dr. Sujuan Ba, the episode dives into...

[vc_row][vc_column][vc_single_image image="63123" img_size="full" alignment="center" css=""][vc_column_text css=""]NFCR-supported researchers Dr. Suzanne Topalian of Johns Hopkins University and her collaborator Dr. Paul Nghiem of the University of Washington co-authored a study titled "A minimal gene set characterizes TIL specific for diverse tumor antigens across different cancer types" that...

[vc_row][vc_column][vc_video link="https://www.youtube.com/watch?v=5xkfbQKugxY&t"][vc_column_text]Pancreatic cancer is one of the most lethal malignancies with few treatment options. Its five-year survival rate is only about 10% in the US. Several treatment options are available for pancreatic cancers, including surgery, chemotherapy, radiation therapy, immunotherapy, and combinational therapies. However, these therapies...

[vc_row][vc_column][vc_single_image image="52821" img_size="full" alignment="center"][vc_column_text css=""]Immunotherapy has changed the landscape of cancer medicine. The good news of its recent success in treating rectal cancer marked a new milestone in cancer treatment. Rectal Cancers Are Gone After the Treatment A research paper published in the New England Journal of Medicine on...

[vc_row][vc_column][vc_single_image image="52814" img_size="full" alignment="center"][vc_empty_space height="22px"][vc_column_text css=""]Melanoma is the deadliest skin cancer as it can quickly spread to other organs and become an untreatable disease. New treatment options such as immunotherapy may help control some patients’ melanoma metastasis, but in most cases, metastatic melanoma still causes the...

[vc_row][vc_column][vc_single_image image="47798" img_size="full"][vc_column_text css=""]Ocular melanoma or uveal melanoma is the most common tumor of eyes in adults. Every year, hundreds of people are diagnosed with this disease. For decades, no effective therapy for the disease existed. Many ocular melanoma patients, thus, have to be treated...